# Metabolic Syndrome Predisposes Ossabaw Minipig Retina to an Early Neurodegenerative Milieu

**Authors:** Scholastica Go, Rayne R. Lim, Anju E. Thomas, Paras K. Mishra, Shyam S. Chaurasia

PMC · DOI: 10.3390/cells15040358 · 2026-02-17

## TL;DR

Ossabaw minipigs fed a Western diet show early signs of retinal degeneration, making them a useful model for studying human retinal diseases linked to metabolic syndrome.

## Contribution

This study demonstrates that metabolic syndrome in Ossabaw minipigs induces an early neurodegenerative environment in the retina.

## Key findings

- Western diet-fed minipigs showed reduced rhodopsin and blue opsins in the retina.
- Obese minipigs exhibited gliosis, microglial activation, and disrupted synaptic connections in retinal layers.
- The findings mimic early stages of diabetic retinopathy and support the use of Ossabaw minipigs as a model for human retinal diseases.

## Abstract

The miniature (mini) Ossabaw pigs are proposed as a translational preclinical model for testing and developing novel therapeutics for human diseases, including cystic fibrosis, cancer, and metabolic syndrome (MetS). In recent years, pigs have gained similar attention for studying retinal abnormalities and disorders owing to their close resemblance in size, anatomy, vasculature, and pathology to the human eye compared with their rodent counterparts. In our previous study, Ossabaw minipigs fed a Western diet for 10 weeks and followed for 3.5 months exhibited early signs of retinal degeneration and vascular abnormalities, mimicking the early stages of diabetic retinopathy (DR). To further evaluate pathomorphological alterations across neuronal and non-neuronal cell types, the present study comprehensively investigated individual retinal layers using cell-type-specific immunostaining. We found that the Western diet-fed mini pigs had reduced rhodopsin and blue opsins, changes in bipolar and ganglion cells, and reduced density of pre- and post-synaptic connections. Moreover, the retinas of obese mini pigs showed evidence of gliosis and microglial activation. Our findings suggest that a Western diet-induced metabolic disorder exhibits an early neurodegenerative milieu and further demonstrate the suitability of Ossabaw mini pigs as a model for human retinal diseases associated with MetS, such as DR and diabetic macular edema (DME).

## Linked entities

- **Proteins:** rhodopsin (rhodopsin-like)
- **Diseases:** metabolic syndrome (MONDO:0000816), cystic fibrosis (MONDO:0009061), cancer (MONDO:0004992), diabetic retinopathy (MONDO:0005266), diabetic macular edema (MONDO:0004728)

## Full-text entities

- **Genes:** PVALB (parvalbumin) [NCBI Gene 100157265] {aka PVALB1}, Ezrin [NCBI Gene 100153898], RCVRN (recoverin) [NCBI Gene 100516153], GLUL (glutamate-ammonia ligase) [NCBI Gene 396944], CALB1 (calbindin 1) [NCBI Gene 100153645], RHO (rhodopsin) [NCBI Gene 397437] {aka PIGRHO1}, S100A9 (S100 calcium binding protein A9) [NCBI Gene 100127489], CMKLR1 (chemerin chemokine-like receptor 1) [NCBI Gene 780421] {aka CMLKR1, GPCR}, GRK7 (G protein-coupled receptor kinase 7) [NCBI Gene 397114] {aka GPRK7}, GFAP (glial fibrillary acidic protein) [NCBI Gene 396562], SYP (synaptophysin) [NCBI Gene 100512029], PRKCA (protein kinase C alpha) [NCBI Gene 397184]
- **Diseases:** neuroretinal disorders (MESH:D012173), DR (MESH:D003930), cardiovascular diseases (MESH:D002318), DME (MESH:D008269), retinal degeneration (MESH:D012162), insulin resistance (MESH:D007333), dry eye syndrome (MESH:D015352), Gliosis (MESH:D005911), hypertension (MESH:D006973), vitreous detachment (MESH:D020255), age-related eye diseases (MESH:D005128), glucose intolerance (MESH:D018149), CRAO (MESH:D015356), depression (MESH:D003866), degeneration (MESH:D009410), T2DM (MESH:D003924), cataracts (MESH:D002386), dysfunction (MESH:D006331), retinal abnormalities (MESH:D012164), Bipolar (MESH:D001714), glaucoma (MESH:D005901), diabetes (MESH:D003920), vascular abnormalities (MESH:D014652), cancer (MESH:D009369), Rod degeneration (MESH:D000071700), AMD (MESH:D008268), cystic fibrosis (MESH:D003550), loss (MESH:D016388), hyperglycemia (MESH:D006943), MetS (MESH:D024821), injury to (MESH:D014947), Neurodegenerative (MESH:D019636), chronic inflammation (MESH:D007249), Muller dysfunction (MESH:C537370), dyslipidemia (MESH:D050171), Vision loss (MESH:D014786), metabolic disorder (MESH:D008659), disorders (MESH:D009358), obese (MESH:D009765), stroke (MESH:D020521)
- **Chemicals:** aspartate (MESH:D001224), 2-methylbutane (MESH:C067038), carbohydrate (MESH:D002241), Fluoro-Jade C (MESH:C534582), Alexa Fluor secondary antibody (-), dopamine (MESH:D004298), PBS (MESH:D007854), glucose (MESH:D005947), DAPI (MESH:C007293), fructose (MESH:D005632), ATP (MESH:D000255), sucrose (MESH:D013395), nitrogen (MESH:D009584), triglycerides (MESH:D014280), OCT (MESH:C051883), phosphoinositide (MESH:D010716), glutamate (MESH:D018698), GABA (MESH:D005680), retinaldehyde (MESH:D012172), malate (MESH:C030298), STZ (MESH:D013311)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Sus scrofa (pig, species) [taxon 9823]
- **Cell lines:** RPE — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939723/full.md

---
Source: https://tomesphere.com/paper/PMC12939723